Update on the causes of platelet disorders and functional consequences

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Platelets, essential for primary hemostasis, originate from megakaryocytes.
• Defects in megakaryocyte differentiation, platelet formation, or function lead to bleeding disorders.
• Thrombopathies manifest as mucous membrane bleeding or post-traumatic/surgical hemorrhage.

Purpose of the Study:

• To classify inherited platelet bleeding disorders (IPD) based on defective pathways.
• To highlight recent advancements in genetic discovery for IPD.
• To outline future research directions in IPD etiology.

Main Methods:

• Classification of IPD by underlying defective pathways (e.g., transcription regulation, TPO signaling, cytoskeletal organization, apoptosis, granule trafficking, receptor signaling).
• Review of platelet function testing for molecular defect insights.
• Application of new-generation genetic approaches for gene discovery.

Main Results:

• Recent genetic studies identified novel genes (NBEAL2, RBM8A, ACTN1, GFI1B) linked to gray platelet syndrome, thrombocytopenia-absent radius syndrome, and autosomal dominant thrombocytopenias.
• Platelet function testing aids in identifying molecular defects.
• A significant number of IPDs remain of unknown genetic etiology.

Conclusions:

• Novel genetic discoveries are advancing the understanding of IPD.
• Future research will likely identify more genes responsible for IPDs of unknown etiology.
• A systems biology approach is crucial for elucidating the roles of mutated genes in megakaryocyte and platelet biology.